41
Otoneurología 2014:
comprendiendomejor los trastornos vestibulares
SUPLEMENTO
original
Actual.Med.
2014; 99: (791). Supl. 41-60
43. MagisD,BoonE,CoppolaG,DaronA, Schoenen J.AnovelCACNA1A
mutationresults inepisodicataxiawithmigrainous featureswithout
headache. Cephalalgia. 2012;32(15):1147-9.
44. Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman
E; Quality Standards Subcommittee of the American Academy of
Neurology and the American Headache Society. Evidence-based
guideline update: NSAIDs and other complementary treatments
for episodic migraine prevention in adults: report of the Quality
Standards Subcommittee of the American Academy of Neurology
and theAmericanHeadacheSociety.Neurology. 2012;78(17):1346-
53.
45. Whitney SL, Wrisley DM, Brown KE, Furman JM. Physical therapy
formigraine-relatedvestibulopathyandvestibulardysfunctionwith
historyofmigraine. Laryngoscope. 2000;110(9):1528-34.
46. Wrisley DM, Whitney SL, Furman JM. Vestibular rehabilitation
outcomes in patients with a history of migraine. Otol Neurotol.
2002;23(4):483-7.
47. Gottshall KR, Moore RJ, Hoffer ME. Vestibular rehabilitation for
migraine-associateddizziness. Int Tinnitus J. 2005;11(1):81-4.
48. Vitkovic J, Winoto A, Rance G, Dowell R, Paine M. Vestibular
rehabilitation outcomes in patients with and without vestibular
migraine. JNeurol. 2013;260(12):3039-48.
49. Silberstein SD. Emerging target-based paradigms to prevent and
treatmigraine. ClinPharmacol Ther. 2013;93(1):78-85.
50. Maldonado Fernández M, Birdi JS, Irving GJ, Murdin L.
Pharmacological treatment for the prevention of vestibular
migraine (Protocol). Cochrane Database of Systematic Reviews
2013, Issue6. Art. No.: CD010600.
